Internal Medicine, Cardiovascular Disease · Philadelphia, PA
NPI
1801827597
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
51 N 39th St, 4th Floor
Philadelphia, PA, 19104
Phone (215) 662-9189
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
2,737 services
Medicare patients, 2024
650
Average age 76
Drug cost, 2024
$33.6M
6,207 prescriptions
Company payments, 2025
$18K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian M Drachman was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 525 times for 338 patients. In total Brian M Drachman billed 2,737 services in 34 codes, and Medicare paid $121K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 525 | 338 | $13.13 | $6,893 |
| 99214 Office E&M - Established | Office | 525 | 335 | $95.37 | $50K |
| 93000 Electrocardiogram | Office | 432 | 326 | $11.05 | $4,775 |
| 93010 Electrocardiogram | Facility | 275 | 185 | $5.82 | $1,599 |
| 99214 Office E&M - Established | Facility | 264 | 139 | $69.75 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 263 | 140 | $12.59 | $3,311 |
| 99232 Hospital E&M - Subsequent | Facility | 77 | 28 | $63.41 | $4,883 |
| 99215 Office E&M - Established | Office | 41 | 39 | $134.69 | $5,522 |
| 93224 Electrocardiogram | Office | 32 | 31 | $54.37 | $1,740 |
| 99233 Hospital E&M - Subsequent | Facility | 25 | 15 | $95.57 | $2,389 |
| 99215 Office E&M - Established | Facility | 22 | 20 | $100.60 | $2,213 |
| 93228 Electrocardiogram | Office | 19 | 18 | $20.25 | $385 |
| 99205 Office E&M - New | Office | 17 | 17 | $177.16 | $3,012 |
| 99205 Office E&M - New | Facility | 12 | 12 | $140.66 | $1,688 |
| 99239 Hospital Discharge Management | Facility | 11 | 11 | $92.27 | $1,015 |
By year: 2022 $138K for 2,116 services; 2023 $120K for 1,967 services; 2024 $121K for 2,737 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian M Drachman prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 1,013 prescriptions and refills. In total Brian M Drachman wrote 6,207 Medicare prescriptions that cost $33.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 1,013 | 1,311 | 133 | $28.2M |
| Metoprolol Succinate Generic | 480 | 1,357 | 151 | $9,974 |
| Furosemide Generic | 412 | 1,112 | 151 | $3,407 |
| Atorvastatin Calcium Generic | 398 | 1,183 | 122 | $5,422 |
| Rosuvastatin Calcium Generic | 298 | 865 | 88 | $4,941 |
| Eliquis Apixaban | 276 | 643 | 81 | $360K |
| Entresto Sacubitril/Valsartan | 243 | 573 | 65 | $356K |
| Losartan Potassium Generic | 200 | 575 | 62 | $2,178 |
| Amlodipine Besylate Generic | 195 | 574 | 70 | $1,343 |
| Carvedilol Generic | 194 | 551 | 63 | $2,378 |
| Vyndaqel Tafamidis Meglumine | 182 | 192 | 20 | $3.9M |
| Spironolactone Generic | 161 | 468 | 60 | $1,754 |
| Lisinopril Generic | 158 | 462 | 56 | $1,659 |
| Potassium Chloride Generic | 158 | 456 | 57 | $12K |
| Farxiga Dapagliflozin Propanediol | 132 | 358 | 47 | $190K |
Brand drugs: 2,237 claims; generic drugs: 3,970 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian M Drachman $18K ($17K in general payments such as food, travel and fees and $1,400 for research) from 5 companies. The largest payer was Pfizer Inc. with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.